# Urine Concentrations of Vilanterol After Inhaled Administration of Vilanterol/Fluticasone Furoate

> **NCT03739294** · PHASE2 · COMPLETED · sponsor: **Bispebjerg Hospital** · enrollment: 26 (actual)

## Conditions studied

- Pharmacokinetics

## Interventions

- **DRUG:** Fluticasone Furoate/ Vilanterol Trifenatate

## Key facts

- **NCT ID:** NCT03739294
- **Lead sponsor:** Bispebjerg Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-08
- **Primary completion:** 2020-12-14
- **Final completion:** 2020-12-14
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2021-01-27

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03739294

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03739294, "Urine Concentrations of Vilanterol After Inhaled Administration of Vilanterol/Fluticasone Furoate". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03739294. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*